by Sue Robbins | Jul 23, 2019 | Migraine
Migraine patients fared as well when managed for a year by telemedicine as did patients managed by a 12-month series of routine office visits in a single-center, randomized trial with 40 patients Read more here.
by Sue Robbins | Jul 22, 2019 | Migraine
The level of exposure to white light is associated with acute risk of headache onset in patients with episodic migraine, according to research presented at the annual meeting of the American Headache Society. The data raise the question of whether modifying light...
by Sue Robbins | Jul 18, 2019 | Migraine
New daily persistent headache (NDPH) presents with a sudden onset headache which continues without remission within 24?h. Although rare, NDPH is important because it is one of the most treatment refractory primary headache disorders and can be highly disabling to the...
by Sue Robbins | Jul 16, 2019 | Migraine
People who experience acute migraine may soon find relief in a new treatment. The results of a clinical trial of a novel drug revealed that it can eliminate head pain and reduce other symptoms of migraine. Read more here.
by Sue Robbins | Jul 15, 2019 | Migraine
Research in an animal model of headache suggests that different underlying mechanisms at work in migraine may explain why some calcitonin gene-related peptide inhibitors, such as fremanezumab, may not work for everyone. Read more here.
by Dr Robbins | Jul 13, 2019 | Migraine
In this cross-sectional observational study with 256 students, researchers explored whether a later high school start time was correlated with lower migraine frequency in high school students with migraine. Using social media, participants were recruited nationally....
